New Initiative – Set to Leverage Data from Human Phenotype Project – Aims to Bring Life Sciences Products to Market with Focus on Enhancing Overall Human Wellbeing

MILL VALLEY, Calif., TOKYO and HERZLIYA, Israel, Oct. 22, 2025 — Corundum Neuroscience (CNS), the neuroscience venture builder and fund, and Corundum Systems Biology (CSB), a leading investor in life-changing systems biology solutions for human health, announced today they will form a new venture creation initiative in collaboration with Offline Studio, a venture studio revolutionizing technological product creation. Offline Studio is the incubation arm of Offline Ventures, the firm’s in-house engine for creating and launching new companies across AI, hard tech, health, and consumer sectors.

Projects funded through the initiative will leverage data from the Human Phenotype Project (HPP) to develop and bring to market new life sciences products that will enhance overall human wellbeing. HPP is a large-scale deep-phenotyping project leveraging AI to derive critical insights from human health data across diverse global populations.

“This new venture initiative offers an exciting opportunity for Corundum to play a key role in shaping the future of life sciences and discover new ways to improve global human health,” said Yasushi Yamamoto, CEO and Founder of Corundum Corp. “We are looking forward to bringing our neuroscience and systems biology expertise to this partnership, helping the next generation of entrepreneurs to impact human wellbeing.”

Corundum and Offline will each initially commit one million dollars, with both partners reserving an additional $1.5 million to be invested at later stages. Both organizations will have the option to invest in the new companies through staged investments, maintaining ownership stakes across each growth phase, while inviting new investors as the companies grow.

Alongside its financial commitment, Offline will provide strategic guidance to the ventures, while CNS and CSB will actively participate in ideation and early-stage project development. Offline Studio will play the leading role in the venture creation process, sourcing projects, conducting early-stage validation and overseeing the incorporation of new companies.

“Offline Studio is committed to creating and growing ventures that solve major global health challenges,” said Jordan Hoffner, Head of Business Development at Offline Studio. “We are thrilled to partner with Corundum for this initiative. By rapidly sourcing and validating projects that translate HPP data into real-world products, we can set a new standard for bringing impactful solutions to market.”

The venture process will follow four stages. Initially, Offline Studio will identify potential projects with input from CNS and CSB. Chosen ventures will then develop prototypes and conduct early-stage validation. Offline will then help establish the ventures as new companies, with Corundum and Offline providing funding through staged SAFE investments. The expectation is that these NewCos will scale their products with additional funding provided as the companies meet defined milestones.

About Corundum Neuroscience 

Corundum Neuroscience is a venture builder and fund advancing transformative neuroscience solutions from lab-to-life. The Corundum Neuroscience team combines deep domain expertise with a track-record of venture-building success to accelerate neuroscience solutions across the entire innovation lifecycle. Taking a long-term investment approach, Corundum Neuroscience helps researchers, entrepreneurs and startups develop life-changing solutions that target specific disease areas and outcomes to enhance people’s health, longevity and quality of life. Founded by former Joy Ventures executives, Corundum Neuroscience launched in September 2023, and is headquartered in Herzliya, Israel.

For company updates and information, follow Corundum Neuroscience on LinkedIn or visit: https://cnsfund.com. 

About Corundum Systems Biology

Corundum Systems Biology (CSB) is dedicated to advancing breakthroughs in human health and well-being by supporting groundbreaking companies in the field of systems biology. Committed to the long-term success and impact of its portfolio companies, Corundum Systems Biology offers deep domain expertise, connections to a broad network of industry and scientific leaders, and access to unique sources of health data.

For company updates and information, follow Corundum Systems Biology on LinkedIn or visit https://www.csb.co.jp/.

Media Contact:
Danny Sudwarts
FINN Partners for Corundum
[email protected] 

SOURCE Corundum Neuroscience

Investment from Avenir, with participation from Bain Capital Ventures, Bessemer Venture Partners, and Menlo Ventures will accelerate product development for the new brand operating system founded on taste and discovery

NEW YORK, Oct. 22, 2025 — Shop My Shelf, Inc. dba ShopMy, the curated commerce infrastructure company today announced it has raised $70M in funding at a $1.5 billion valuation. The round was led by Avenir, with participation from Bain Capital Ventures, Bessemer Venture Partners, and Menlo Ventures. The round is also supported by several strategic individuals and firms including Sofia Richie, Gregg Renfrew, Raissa Gerona, Alex Mondre of AGM Ventures, and Aimee Song and Jacopo Moschin. ShopMy operates the only integrated marketing system serving premium brands, culture-driving tastemakers, and discerning consumers through technology built for lasting businesses rather than quick marketing campaigns. ShopMy began by serving creators, then brought brands into the ecosystem, and is now directly serving consumers.

“ShopMy is fundamentally a bet on authenticity and that lasting brand value comes through curation and taste over ads and algorithmic recommendations, enabling consumers to discover and buy the world’s best products,” said Harry Rein, CEO of ShopMy.

ShopMy has demonstrated significant growth across recent key metrics:

• Over $1B in annual platform sales through curators sharing recommendations
• 185,000+ hand-picked tastemakers focused on quality over volume
• 1,200+ premium brand partners building lasting relevance
• 30,000+ Circles and 150,000+ wishlisted products since the consumer platform launch in August. Circles curates personalized shopping feeds from multiple trusted creators, replacing algorithmic recommendations with human curation.
• 200% revenue growth year over year
• Sustained profitability since 2024

“Word of mouth has always been the most powerful force in commerce, and we’re building the infrastructure to make it scalable,” said Tiffany Lopinsky, President of ShopMy. “We have deep conviction that curators are the future of brand distribution for the next generation of enduring companies. This investment lets us transform personal enthusiasm into measurable results at scale.”

“ShopMy has cracked the code on making creator commerce work for elevated brands without diluting their positioning,” said Andrew Sugrue, Founder at Avenir. “When we evaluated the opportunity, the explosive growth was undeniable—they’ve created a complete solution that’s taken off in 2025, representing a fundamentally better version of how commerce should work.”

Founded in 2020 by Harry Rein (CEO), Tiffany Lopinsky (President), and Chris Tinsley (CBDO), ShopMy has evolved from individual creator storefronts to a multi-curator approach and facilitates over a $1B in annual sales for brands building lasting cultural relevance through authentic recommendations rather than traditional advertising. ShopMy integrates the complete commerce ecosystem, from brand partnerships to consumer discovery, in one professional system designed to surface the world’s best products.

About ShopMy ShopMy builds creator commerce infrastructure that connects premium brands, curators, and consumers through taste and trust. With professional tools, performance data, and a network of 185,000+ curated tastemakers, ShopMy helps brands like Rhode, Kallmeyer, Net-a-Porter, Gucci, West Elm, and Therabody drive measurable results while building enduring cultural relevance through authenticity over advertising. Based in NYC with a new Gramercy office space, the team of 140+ continues to scale the platform that’s redefining creator commerce in more than 130 countries .

Media Contact: [email protected]

SOURCE Shop My Shelf, INC.

• Electra Therapeutics is a late-stage biotechnology company developing new medicines for people with serious immunological and cancer-related diseases
• Financing was co-led by EQT Life Sciences and Nextech, with participation from Sanofi, HBM Healthcare Investments, Mubadala Capital, and all existing investors
• Proceeds will fund the registrational Phase 2/3 clinical study of the lead program in secondary hemophagocytic lymphohistiocytosis (sHLH), a life-threatening hyperinflammatory disease with no approved therapies
• Funding will also support expanding the lead program into hematologic cancers and establishing clinical proof-of-mechanism for a second program, with broad potential across immunology and inflammation

AMSTERDAM, Oct. 22, 2025 — EQT Life Sciences is pleased to announce that its LSP 7 fund has invested in Electra Therapeutics, a late-stage US biotechnology company developing innovative treatments for immune-mediated diseases and cancer. Electra is advancing a new class of precision medicines designed to selectively target overactive immune cells that drive disease, while preserving normal immune function. This differentiated approach has the potential to deliver more effective and durable therapies for patients affected by serious immune-mediated and inflammatory conditions.

The USD 183 million Series C will fund the global registrational Phase 2/3 clinical study of the lead program (ELA026) in secondary hemophagocytic lymphohistiocytosis (sHLH) and establish clinical proof-of-mechanism for Electra’s second program (ELA822) that has broad potential across immunology. The round was co-led by EQT Life Sciences and Nextech, with participation from new investors Sanofi, HBM Healthcare Investments, and Mubadala Capital, alongside all existing investors.

sHLH is a severe and life-threatening inflammatory condition triggered by underlying diseases such as cancer, autoimmune disorders, or serious infections. It causes the immune system to go into overdrive, leading to widespread inflammation and organ failure. There are currently no FDA-approved treatments for sHLH broadly, and in cancer-associated sHLH, survival at 8 weeks is only about 50 percent with existing options. Electra’s ELA026 is an antibody targeting Signal Regulatory Proteins (SIRP), cell surface receptors found on immune cells that become overexpressed in inflammatory diseases. By precisely removing these harmful cells while sparing normal immune function, ELA026 is designed to stop the inflammatory process at its source. This approach represents a novel way to rebalance the immune system and could have broader applications across multiple immune-mediated diseases.

Early clinical data are highly encouraging. In a Phase 1b study in sHLH, ELA026 achieved 100 percent survival at 8 weeks in frontline-treated patients. While preliminary, these results support the premise that precisely depleting SIRP-expressing immune cells can rapidly restore immune balance and may represent a meaningful advance for patients with this devastating condition. ELA026 has received FDA Breakthrough Therapy and EMA Priority Medicines designations for sHLH.

“We are pleased to have the support of a distinguished group of investors who share our vision to deliver life-changing treatments for patients with underserved diseases,” said Kathy Dong, PharmD, MBA, President and CEO of Electra Therapeutics. “Our team has a proven record of translating novel biology into first-in-class breakthrough therapies, as exemplified by ELA026. With strong momentum, we are driving the pivotal study of ELA026 in sHLH forward and accelerating our second SIRP-targeted program into the clinic.”

“The Electra team has demonstrated exceptional scientific and clinical execution in advancing a first-in-class therapy for patients with no approved treatment options,” said Christoph Broja, Partner in EQT Life Sciences, who will join Electra’s board as observer. “We are impressed by the clarity of Electra’s approach and the quality of its early data, and we look forward to supporting the team as it drives its pivotal program forward and explores the broader potential of SIRP-targeted therapies to bring real innovation to patients.”

Contact
EQT Press Office, [email protected]

This information was brought to you by Cision http://news.cision.com.

https://news.cision.com/eqt/r/eqt-life-sciences-co-leads-usd-183-million-series-c-financing-in-electra-therapeutics,c4253937

The following files are available for download:

Series A Positions Innovative New Fintech to Launch First-Of-Its-Kind, Second-Look Private Student Lending Program for Spring 2026 Semester

WILMINGTON, Del., Oct. 22, 2025 — GradBridge, a newly launched fintech focused exclusively on second-look private student lending, today announced the closing of a $20 million Series A funding round led by Acorn Investment Partners, a portfolio company of funds managed by Oaktree Capital Management L.P. (“Oaktree”). The equity investment will support GradBridge’s upcoming launch of a first-of-its-kind private student loan product exclusively designed for students who have exhausted federal and private options and are still committed to completing their education.

“Acorn’s principals have a long history of partnering with strong entrepreneurial businesses, and through this investment support expanded access to higher education for deserving students, while delivering attractive risk-adjusted returns,” said Yadin Rozov, CIO of Acorn Investment Partners. “GradBridge’s approach addresses a real market gap for students who are performing academically but fall just outside of traditional credit underwriting models. We are proud to lead this round and support their launch.”

Founded by former Sallie Mae executive Jen O’Donald, GradBridge is led by a seasoned team of financial services and student lending veterans with decades of experience in consumer credit, operations, and customer experience. Key leadership includes CFO Brian Carp, COO Lisa Kaplan, and support from a network of advisors that includes Paul Thome, former President of Sallie Mae Bank and Dan Hill, former Chief Credit Officer of Sallie Mae.

To ensure operational excellence and regulatory compliance from the outset, GradBridge has partnered with established industry leaders including CampusDoor, Nelnet, Gestalt, and Maquette Advisors, who together provide the origination technology, servicing, and analytics needed to scale responsibly.

“College completion is one of the most powerful drivers of lifetime earnings and financial independence, yet every year, more than a million students are denied private loans—many by just a narrow margin. Changes to the federal student loan program will only exacerbate this reality,” said Jen O’Donald, CEO of GradBridge. “We see an unserved, addressable market for our innovative product: academically strong students who fall outside traditional student loan underwriting criteria and risk not completing their degree. With the backing of Acorn Investment Partners, we now have the resources needed to give these underserved students a second look – and a second chance to bridge the gap between ambition and opportunity.”

GradBridge is poised to address one of higher education’s most pressing challenges: helping students stay in school and graduate when traditional financing falls short. Today more than half of undergraduates at four-year schools drop out, and financial struggles top the list of reasons why. According to the Bureau of Labor Statistics, college dropouts earn 30% less than college graduates and are 50% more likely to be unemployed.

Ultimately, GradBridge aims to help students everywhere achieve their academic and financial goals. 

For more information, visit gradbridge.com, or to schedule an interview, contact [email protected].

About GradBridge
GradBridge is a fintech company focused exclusively on second-look private student lending designed to transform how students access the funding they need to graduate. Founded by veteran student loan executives, GradBridge provides a first-of-its-kind, student lending approach for upperclassmen and graduate students who are making academic progress but narrowly miss approval from traditional lenders. With a mission to close the gap between ambition and opportunity, GradBridge transforms loan denials into graduation success stories, unlocking long-term financial independence and brighter futures. Learn more at www.gradbridge.com.

Media Contacts
ShinePR for GradBridge
[email protected]

About Acorn Investment Partners
Acorn Investment Partners is a specialized investment firm focused on insurance asset management, specialty finance investments, and off-the-run special situations. The firm is led by experienced professionals with decades of combined experience across a variety of asset classes and investment types, including structured finance, insurance solutions, and growth equity. Founded in 2025, Acorn Investment Partners, a portfolio company of funds managed by Oaktree Capital Management, L.P., takes a modern and proprietary approach to asset management. 

SOURCE GradBridge

The platform cuts international payment times from weeks to hours, reducing costs by 95%

NEW YORK, Oct. 21, 2025 — Tesser today announced it has secured seed funding for its stablecoin payments solution in a round led by Castle Island Ventures alongside Strobe Ventures and Anthemis with participation from other strategic investors.

Founded by Geetha Panchapakesan, a payments veteran who spent 18 years at MoneyGram, Visa Direct, and Circle, Tesser addresses a critical gap: licensed financial institutions want to enable stablecoins but lack the technical infrastructure to do so quickly and compliantly.

Why this matters for financial institutions

Visa’s global payment volume in 2024 was 13.2 trillion. Stablecoin payment volume in the same year reached $6.4 trillion – nearly half of that, most of which is market share being captured from traditional institutions.

Tesser’s stablecoin payment platform can help financial institutions cut cross border payments delivery time to hours with a 95% cost reduction over industry standards.  The platform, which can be fully integrated in under a month, handles wallet provisioning, treasury management, compliance orchestration, and reconciliation—abstracting blockchain complexity and allowing institutions to maintain full control over risk and customer relationships.

“We’re giving institutions the full stack infrastructure to add blockchain as a payment rail, the same way they added mobile payments. We are the only platform that doesn’t seek to compete with banks, PSPs or fintechs, but support them” Panchapakesan said.

Tesser’s MVP launches at Money 2020 in Las Vegas, October ’25. To learn more about the platform, sign up for updates at tesser.xyz/updates or connect with Tesser at Money 2020.

About Tesser

Founded in 2025 and based in New York, Tesser provides licensed financial institutions with a full-stack platform to connect traditional finance with blockchain-based money movement.

Media Contact:
[email protected]

SOURCE Tesser Payments Inc DBA Tesser

JANA plans to engage with the Company’s Board of Directors and management regarding opportunities to enhance shareholder value and improve the guest experience. JANA Managing Partner Scott Ostfeld disclosed the investment at the 13D Monitor Active-Passive Investor Summit.

“I am a lifelong Six Flags fan and grew up going to these parks with my family and friends,” said Travis Kelce. “The chance to help make Six Flags special for the next generation is one I couldn’t pass up.”

“We look forward to working with the Six Flags board and management to unlock shareholder value for the benefit of all stakeholders,” added Scott Ostfeld.

About Glenn Murphy

Glenn Murphy is an accomplished consumer executive who brings a 30-year track record of strategic and operational leadership across multiple major global brands. He is the founder and Chief Executive Officer of FIS-Holdings Ltd., a high‐impact consumer‐focused investment firm. Prior to FIS Holdings, Mr. Murphy served as Chairman and Chief Executive Officer of Gap, Inc. from 2007 until 2014. Prior to that, he served as the Chairman and Chief Executive Officer of Shoppers Drug Mart Corporation from 2001 to 2007. Mr. Murphy currently serves as Executive Chair of the board of Petco Health and Wellness Company, as well as Executive Chair of Wella Beauty. He previously served as Executive Chairman and then Chairman of the board of directors of Lululemon Athletica, Inc. from April 2017 to August 2023.

About Dave Habiger

Dave Habiger is an accomplished technology and media executive who brings decades of leadership experience across multiple global companies. He currently serves as Vice Chairman of J.D. Power, where he previously served as President and Chief Executive Officer from 2018 to 2025. Over his career, Mr. Habiger has led several public technology businesses through significant growth and strategic transactions, including serving as Chief Executive Officer of Textura Corporation through its sale to Oracle in 2016, Chief Executive Officer of NDS Group through its sale to Cisco Systems in 2012, and President and Chief Executive Officer of Sonic Solutions through its sale to Rovi Corporation. Mr. Habiger serves on multiple public and private company boards including as Chairperson of Reddit, and as a director for Boston Scientific and the Chicago Federal Reserve Board.

About JANA Partners

JANA Partners was founded in 2001 by Barry Rosenstein. JANA invests in undervalued public companies and engages with management teams and boards to unlock value for shareholders.

Disclaimer

This press release and the opinions herein are for general information only, and are not intended to be, nor should they be construed as, an offer to sell or a solicitation of an offer to buy any security, a recommendation to purchase or sell any security, or legal, financial, tax, investment, or other advice. Funds managed by JANA currently beneficially own and have other economic interests in shares of the Company. Travis Kelce has a financial interest in certain of the Company’s securities, including, but not limited to, investments relating to the Company in such funds managed by JANA. These funds are in the business of trading (i.e., buying and selling) securities and intend to continue trading in the securities of the Company. You should assume such funds, as well as other funds in which Travis Kelce has a financial interest, may from time to time sell all or a portion of their respective holdings of the Company in open market transactions or otherwise, buy additional shares (in open market or privately negotiated transactions or otherwise), or trade in options, puts, calls, swaps or other derivative instruments relating to such shares, subject to applicable law. Consequently, JANA’s or Travis Kelce’s beneficial ownership of shares of, and/or economic interest in, the Company may vary over time depending on various factors, with or without regard to their respective views of the Company’s business, prospects, or valuation (including the market price of the Company’s shares), including without limitation, other investment opportunities available to them, concentration of positions in the portfolios managed by them, conditions in the securities markets and general economic and industry conditions. JANA and Travis Kelce each reserve the right to change any of their respective opinions expressed herein at any time as they deem appropriate and disclaim any obligation to notify the market or any other party of any such change, except as required by law.

Press Contacts

Jonathan Gasthalter/Nathaniel Garnick
Gasthalter & Co.
[email protected]
(212) 257-4170

SOURCE JANA Partners

Funding to Accelerate Product Evolution and Go-to-Market Strategies to Grow the Business

MINNEAPOLIS, Oct. 21, 2025 — Gravwell, the full-stack data analytics and security platform, today announced the closing of $15.4 million in Series A funding led by Two Bear Capital. The round included participation from Gula Tech Adventures, Next Frontier Capital, and others. Gravwell enables organizations to collect, observe, and analyze “ground truth” data from IT and OT systems to stay operational and secure. The new investment will accelerate the evolution of Gravwell’s product offering, enabling it to deliver solutions that address rapidly emerging use cases for data analysis and security. Funding will also support go-to-market strategies designed to build on the company’s current momentum. Gravwell has achieved over 100% year-over-year growth fueled by both national and international demand. The growth was driven largely by organizations seeking a modern, high-performance alternative to legacy market leaders. These organizations are looking to enhance operations with Gravwell’s unique ability to handle sophisticated, large data sets. Additional capital will help the company keep up with growing demand while maintaining its highly lauded customer service.

Enterprises rely on Gravwell to centralize massive volumes of logs, accelerate cybersecurity threat hunting, and gain unprecedented visibility across their environments, including the emerging challenge of auditing AI agent activity. By ingesting and analyzing every event, command, and interaction, Gravwell helps organizations detect anomalies, investigate threats, and ensure AI systems behave as intended.

“With demand for both advanced log management and trustworthy AI oversight surging, the real time tools and solutions Gravwell provides have never been more critical,” said Mike Goguen, founder and managing partner of Two Bear Capital. “Gravwell gives enterprises the power to hunt threats, manage logs at scale, and audit what their AI agents are doing to deliver the visibility and trust modern security teams need to be safe and successful in business. Two Bear Capital is excited to be investing in Gravwell during this transformative moment. I look forward to working with founders Corey Thuen and Kris Watts to help Gravwell realize all the opportunity and potential ahead of it.”

“Built-from-scratch, Gravwell was designed to ingest data in its unprocessed format, operate at an enterprise scale with minimal maintenance, and provide best-in-class tools to investigators looking to find out what really happened; whether investigating a potential cybersecurity breach, gaining visibility into unique environments like on-prem OT, or keeping things running, data is the key to understanding,” said Corey Thuen, CEO and co-founder of Gravwell. “We are grateful to Two Bear Capital, Gula Tech Adventures, and all of our investors who understand our mission and believe in the company we are building.”

About Gravwell
Gravwell is a full-stack data analytics and security platform purpose-built for high-volume, high-fidelity machine data. By enabling organizations to ingest, index, and query logs, network traffic, and event streams at scale, Gravwell empowers security teams to rapidly investigate threats, detect anomalies, and meet compliance requirements without data silos or sampling. With a flexible ingestion engine and vendor-agnostic architecture, Gravwell delivers deep visibility across IT and OT environments, arming defenders with the speed and context needed to outpace modern adversaries. Gravwell investors include Two Bear Capital, Gula Tech Adventures, Innosphere Ventures Fund, Next Frontier Capital, Kickstart, and Rise of the Rest. For more information, visit: www.gravwell.io.

About Two Bear Capital
Founded in 2019 by Mike Goguen, Two Bear Capital is a venture capital firm investing in brilliant entrepreneurs with breakthrough solutions to complex and critical problems. With its unique approach to venture capital, Two Bear Capital’s vision is to build enduring, high-impact businesses that benefit society while delivering for investors. The firm primarily focuses on early founder-led companies with disruptive life sciences and technology innovations. Two Bear Capital has offices in Menlo Park, San Diego, Boston, and New York, with its home base in Whitefish, Montana. For more information, visit: www.twobearcapital.com.

Media Contact:
Barrett Louie
[email protected]

SOURCE Gravwell

Enterprises building AI-powered applications are stuck with fragmented data stacks, brittle DIY pipelines, costly batch tools, or fragile streaming-first systems. Batch pipelines introduce hours of latency, while streaming stacks are powerful but brittle, expensive, and require heavy operations. This results in spiraling costs, complexity, outages, and AI projects stalling when fresh data isn’t available.

Estuary’s platform solves this problem by merging real-time and batch data movement so organizations can capture, transform, and sync data continuously across their entire stack in one place. With Estuary, enterprises cut spend by 40–60%, accelerate time-to-market for streaming solutions, and gain fine-grained control over latency and deployment, whether SaaS, private plane, or Bring Your Own Cloud (BYOC) The result: dependable, affordable data that’s synchronized at the right time for every workflow.

“Data integration has long meant stitching together multiple vendors and making painful tradeoffs,” said David Yaffe, co-founder and CEO of Estuary. “We built Estuary to eliminate those compromises. By unifying batch and streaming, and letting customers dial latency anywhere from sub-second to scheduled, we give enterprises dependable pipelines that fuel analytics, operations, and AI at lower cost.”

“This raise allows us to accelerate toward a future where pipelines simply work, where data moves when and how teams need it, powering both today’s analytics and AI,” Yaffe added.

As enterprises race to adopt AI, the need for dependable, fresh data has never been greater. Most legacy systems are either brittle DIY pipelines or costly vendor stacks that lack flexibility. Estuary Flow bridges this gap, offering:

• One platform for all data movement: Replace CDC, batch, and streaming tools with a single managed platform.
• Right-time performance: Control data latency like a dial: sub-second, near real-time, or batch, aligning cost and speed with workload needs.
• Enterprise-grade reliability & control: Exactly-once semantics, deterministic recovery, targeted backfills, and flexible deployment (SaaS, BYOC, or private data plane).
• Predictable, lower TCO: 40-60% cost savings vs. MAR-based models, with throughput or flat-fee pricing options.
• Partner-level support: Rapid connector delivery, SLAs, and hands-on guidance for mission-critical workloads.

“For AI systems like ours, freshness of data is everything. Estuary gives us sub-second latency without the complexity of maintaining streaming infrastructure ourselves. That reliability means our teams can focus on advancing AI models instead of pipelines,” said YuTong (Julia) Zhang, Senior Software Engineer at Together AI.

“Estuary has been a pleasure to work with and has significantly modernized our data infrastructure, delivering real-time and scalable processes that will significantly impact company-wide operations. Every data-driven organization should be looking at Estuary today,” said Andrew Woelfel, Senior Manager, Data Engineering and Analytics at Xometry.

Customers across finance, healthcare, logistics, and SaaS already rely on Estuary to consolidate stacks, cut costs, and modernize their data infrastructure.

“M13 is excited to back Estuary as they redefine enterprise data movement,” said M13’s Managing Partner Karl Alomar. “Having scaled DigitalOcean from startup to global infrastructure provider, I’ve seen firsthand how critical dependable, cost-predictable systems are for enterprises. Estuary’s ‘right-time’ approach, unifying batch and streaming with BYOC flexibility, solves enterprises’ complexity and compliance challenges, modernizes data stacks and lays the foundation for AI-driven workloads.”

With this Series A, Estuary will expand engineering, product, and go-to-market teams to scale its enterprise roadmap and global reach.

For more information, visit www.estuary.dev.

About Estuary

Estuary is the right-time data platform that replaces fragmented data stacks by consolidating CDC, streaming, batch, and pipelines into a single managed system. With Estuary, enterprises gain predictable pricing and fine-grained control over latency with flexible deployment options – all in one platform.

Press contact

Daniel Palma
Head of Marketing
Estuary
Email: [email protected]
Phone: 347-891-2483

SOURCE Estuary Technologies, Inc.

Funding accelerates Findem’s mission to build the next generation of Talent AI

SAN FRANCISCO, Oct. 21, 2025 — Findem, the only AI talent acquisition and management solution powered by 3D data, today announced $51 million in new funding. The raise includes a Series C led by SLW, with participation from Wing Ventures, Harmony Capital and Four Rivers Group, and growth financing from J.P. Morgan. This brings Findem’s total funding to $105 million.

This raise follows a year of exceptional momentum, with 3X year-over-year growth, top-10% placement on the Inc. 5000, and recognition by Fortune and Fast Company as one of America’s most innovative companies.

From Automation to Strategic Impact
AI is reshaping HR, and the breakthrough lies in domain-specific AI that can elevate recruiting beyond task automation to measurable business impact. Most recruiting technologies rely on fragmented public data and resumes, limiting them to surface-level matches without the context behind great hiring decisions. Findem bridges that gap by unlocking the expertise of top recruiters and transforming their habits into AI-ready, data-driven workflows.

Findem’s data labeling engine identifies ‘success signals’—validated patterns that reveal not just who can do the job, but who is most likely to thrive in a specific role, team and culture. It’s how a military logistics officer is understood to be ready for a senior supply chain role, or how leadership potential is spotted in an engineer who has scaled multiple startups. Trained on success signals, Findem’s AI streamlines and elevates workflows, improving the experience for recruiters and candidates, while delivering the cost savings and strategic impact that CHROs value most.

“Findem is pioneering a new category in talent technology, enabling top recruiters to use AI to drive more efficient workflows and land better candidates faster,” said Shawn K. O’Neill, Managing Partner at SLW. “Recruiting expertise is inherently specialized, and the wisdom to identify a future leader or valuable prospect doesn’t exist in public datasets. We invested in Findem because their platform is driving better outcomes for talent teams with more automation and unique insights, making them well positioned to lead the next wave of talent innovation.”

“HR decisions have always been limited by the quality of data. Findem’s data engine, with its uniquely labeled and multi-dimensional people data, decodes important talent information that companies have never seen before,” said Josh Bersin, global industry analyst and CEO of The Josh Bersin Company. “From faster hiring to better retention and workforce agility, Findem is helping companies build the next generation of enterprise people strategy.”

The Largest Expert-Labeled Talent Dataset
Launched in 2020, Findem’s data labeling engine is powered by millions of proprietary attributes, digitizing success signals that used to live only in the heads of great recruiters and hiring managers. This data expands into over 800 million 3D profiles, giving AI the most contextualized view of human potential—far beyond a resume or LinkedIn profile.

“By elevating talent data from a flat commodity into a rich strategic asset, we’re the only company making it AI-ready,” said Findem CEO Hari Kolam. “This is just the beginning of what’s possible when AI truly understands talent.”

Findem will use the new funding to expand its expert-labeled dataset and accelerate the development of domain-specific AI, partnering with companies to transform the people function through its data labeling engine. The investment will also drive the creation of agentic workflows optimized for outcomes, spanning calibration, interviews and everything in between. In addition, the funding will fuel go-to-market initiatives and support Findem’s continued global growth.

Strategic Partnerships Drive Market Expansion
Partners with deep domain expertise are uniting with Findem to build the most advanced AI for talent and transform people decisions.

“Our partnership with Findem addresses one of the toughest challenges in hiring: making veteran talent visible,” said Tim Best, CEO of RecruitMilitary and U.S. Army veteran. “Employers often find it difficult to translate military experience into business terms. By embedding our decades of veteran hiring expertise into Findem’s attributes, we highlight impact, showing how veterans’ skills and leadership directly drive measurable business outcomes.”

“By partnering with Findem, we’re turning our workforce equity expertise into structured attributes that illuminate diverse talent in new ways. Together, we’re ensuring that employers have the data they need to recognize and connect with talent whose skills and impact might otherwise be overlooked,” said Brenda Darden Wilkerson, president and CEO of AnitaB.org.

Looking Ahead
“We’re grateful for the trust of our customers, partners, investors and team,” said Kolam. “Together, we’re turning static talent data into a living, strategic engine that not only fills roles but predicts and shapes the future of work.”

About Findem
Findem’s Talent Data Cloud combines expert-labeled, 3D data with AI to unlock smarter talent strategy and streamline the way businesses connect with top candidates. By bringing together multichannel sourcing, CRM and insights into one place, Findem eliminates inefficiencies and allows TA teams to focus on the right candidates and decisions that drive business impact. Findem empowers customers like RingCentral and Nutanix to solve enterprise challenges at scale, creating continuous pipelines of top, diverse candidates, delivering improved ROI and making great hires. Discover why we’ve been named one of America’s most innovative companies and how we’re transforming hiring at www.findem.ai.

About SLW
SLW was founded in 2012 as Silver Lake Waterman, a later-stage growth strategy within Silver Lake, the global leader in technology investing. In 2024, SLW became an independent firm while maintaining collaborative relationships between SLW and Silver Lake. SLW partners with leading technology companies by investing repeatedly throughout a company’s lifecycle in both equity and flexible non-dilutive structures to meet evolving capital needs. The firm’s long-term, relationship-oriented strategy allows it to be an enduring partner for exceptional founders and management teams, providing flexible capital and strategic support at every phase of growth.

SOURCE Findem